Intimate Wipe

Description

PLAYBOY INTIMATE WIPES are a male genital desensitizer designed to assist in climax delaying. Each wipe is formulated with benzocaine, a local anesthetic that helps reduce sensitivity. The product is fragrance and paraben-free, ensuring a gentle application. Each package contains four individually wrapped climax delaying wipes, providing convenience and hygiene for use.

Uses and Indications

This drug is indicated for the temporary prolongation of the time until ejaculation in adult males.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should instruct patients to apply a small amount of the product to the head and shaft of the penis prior to intercourse, or as directed by a physician. It is essential that the product is thoroughly washed off after intercourse to ensure proper hygiene and effectiveness.

Contraindications

Use of this product is contraindicated in individuals with a history of eye contact, as it may lead to irritation or other adverse effects. There are no additional contraindications specified for this product.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to avoid contact with the eyes during application.

Patients should be instructed to discontinue use and consult a physician if any of the following occur: the product does not provide relief when used as directed, as premature ejaculation may indicate an underlying condition that requires medical supervision; the patient or their partner experiences a rash or irritation, including symptoms such as burning or itching; or if symptoms persist despite use.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. Care should be taken to avoid contact with the eyes, as this may lead to irritation or other adverse effects.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if the product does not provide relief as directed. It is important to note that premature ejaculation may be indicative of an underlying condition that requires medical supervision.

Additionally, if either the patient or their partner experiences a rash or irritation, such as burning or itching, they should stop using the product and seek medical advice. Persistent symptoms should also prompt a consultation with a healthcare provider to ensure appropriate management and care.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Intimate Wipe (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. The potential risks and benefits should be carefully weighed in the context of the individual patient's situation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that they should discontinue use and consult a doctor if the product, when used as directed, fails to provide relief, as premature ejaculation may indicate an underlying condition that requires medical supervision.

Patients should also be instructed to stop using the product and seek medical advice if they or their partner experience any rash or irritation, including symptoms such as burning or itching. Additionally, healthcare providers should emphasize that if symptoms persist, patients should consult a doctor for further evaluation.

Furthermore, it is crucial to remind patients to avoid contact with the eyes while using this product to prevent potential irritation or injury.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature, away from direct sunlight and moisture. To maintain safety, it is essential to keep the product out of reach of children. Once opened, the product must be discarded to ensure proper handling and safety.

Additional Clinical Information

Patients should apply a small amount of the product to the head and shaft of the penis before intercourse, or as directed by a clinician. It is important to wash the product off after intercourse. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Intimate Wipe, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)